Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,848 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis.
Vreeland TJ, Clifton GT, Hale DF, Chick RC, Hickerson AT, Cindass JL, Adams AM, Bohan PMK, Andtbacka RHI, Berger AC, Jakub JW, Sussman JJ, Terando AM, Wagner T, Peoples GE, Faries MB. Vreeland TJ, et al. Ann Surg Oncol. 2021 Oct;28(11):6126-6137. doi: 10.1245/s10434-021-09709-1. Epub 2021 Feb 27. Ann Surg Oncol. 2021. PMID: 33641012 Free PMC article. Clinical Trial.
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis.
Chick RC, Faries MB, Hale DF, Kemp Bohan PM, Hickerson AT, Vreeland TJ, Myers JW 3rd, Cindass JL, Brown TA 2nd, Hyngstrom J, Berger AC, Jakub JW, Sussman JJ, Shaheen M, Clifton GT, Park H, Sloan AJ, Wagner T, Peoples GE. Chick RC, et al. Among authors: berger ac. Cancer Med. 2021 Jul;10(13):4302-4311. doi: 10.1002/cam4.3969. Epub 2021 May 12. Cancer Med. 2021. PMID: 33982452 Free PMC article. Clinical Trial.
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial.
Adams AM, Carpenter EL, Clifton GT, Vreeland TJ, Chick RC, O'Shea AE, McCarthy PM, Kemp Bohan PM, Hickerson AT, Valdera FA, Tiwari A, Hale DF, Hyngstrom JR, Berger AC, Jakub JW, Sussman JJ, Shaheen MF, Yu X, Wagner TE, Faries MB, Peoples GE. Adams AM, et al. Among authors: berger ac. Cancer Immunol Immunother. 2023 Mar;72(3):697-705. doi: 10.1007/s00262-022-03272-8. Epub 2022 Sep 1. Cancer Immunol Immunother. 2023. PMID: 36045304 Free PMC article. Clinical Trial.
Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma.
Kangas-Dick AW, Greenbaum A, Gall V, Groisberg R, Mehnert J, Chen C, Moore DF, Berger AC, Koshenkov V. Kangas-Dick AW, et al. Among authors: berger ac. Ann Surg Oncol. 2021 Aug;28(8):4582-4589. doi: 10.1245/s10434-020-09563-7. Epub 2021 Jan 23. Ann Surg Oncol. 2021. PMID: 33486642
Assessing the immediate impact of COVID-19 on surgical oncology practice: Experience from an NCI-designated Comprehensive Cancer Center in the Northeastern United States.
Gazivoda V, Greenbaum A, Roshal J, Lee J, Reddy L, Rehman S, Kangas-Dick A, Gregory S, Kowzun M, Stephenson R, Laird A, Alexander HR, Berger AC. Gazivoda V, et al. Among authors: berger ac. J Surg Oncol. 2021 Jul;124(1):7-15. doi: 10.1002/jso.26475. Epub 2021 Mar 25. J Surg Oncol. 2021. PMID: 33765341 Free PMC article.
Melanoma.
Berger AC. Berger AC. Surg Oncol Clin N Am. 2015 Apr;24(2):xv-xvi. doi: 10.1016/j.soc.2015.01.001. Surg Oncol Clin N Am. 2015. PMID: 25769720 No abstract available.
FOXD3 Regulates VISTA Expression in Melanoma.
Rosenbaum SR, Knecht M, Mollaee M, Zhong Z, Erkes DA, McCue PA, Chervoneva I, Berger AC, Lo JA, Fisher DE, Gershenwald JE, Davies MA, Purwin TJ, Aplin AE. Rosenbaum SR, et al. Among authors: berger ac. Cell Rep. 2020 Jan 14;30(2):510-524.e6. doi: 10.1016/j.celrep.2019.12.036. Cell Rep. 2020. PMID: 31940493 Free PMC article.
3,848 results